Extracorporeal Carbon Dioxide Removal With the Hemolung in Patients With Acute Respiratory Failure: A Multicenter Retrospective Cohort Study.

ABSTRACT:

Objectives

Extracorporeal carbon dioxide removal (ECCO 2 R) devices are effective in reducing hypercapnia and mechanical ventilation support but have not been shown to reduce mortality. This may be due to case selection, device performance, familiarity, or the management. The objective of this study is to investigate the effectiveness and safety of a single ECCO 2 R device (Hemolung) in patients with acute respiratory failure and identify variables associated with survival that could help case selection in clinical practice as well as future research.

Design

Multicenter, multinational, retrospective review.

Setting

Data from the Hemolung Registry between April 2013 and June 2021, where 57 ICUs contributed deidentified data.

Patients

Patients with acute respirat

SUBMITTER: Tiruvoipati R 

PROVIDER: S-EPMC10262985 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature